Results Snapshot
Figures in Million
Consolidate Annual Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Sep'18
Net Sales
334.64
285.47
178.70
129.41
97.74
80.97
70.51
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
334.64
285.47
178.70
129.41
97.74
80.97
70.51
Raw Material Cost
154.46
126.76
71.87
58.11
46.38
36.55
36.83
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
12.64
10.33
2.66
2.52
2.48
4.30
1.91
Selling and Distribution Expenses
167.25
143.96
105.94
72.97
52.20
45.59
40.53
Other Expenses
-1.26
-1.03
-0.27
-0.25
-0.25
-0.43
-0.19
Total Expenditure (Excl Depreciation)
321.71
270.73
177.82
131.08
98.59
82.14
77.36
Operating Profit (PBDIT) excl Other Income
12.9
14.7
0.8999999999999999
-1.7000000000000002
-0.8
-1.2
-6.800000000000001
Other Income
0.85
0.62
-0.24
-0.10
2.46
-0.02
0.43
Operating Profit (PBDIT)
66.32
57.13
30.07
20.72
21.18
12.77
8.68
Interest
12.64
10.33
2.66
2.52
2.48
4.30
1.91
Exceptional Items
-2.07
-1.75
5.77
-7.51
-3.95
-3.37
0.00
Gross Profit (PBDT)
180.18
158.70
106.82
71.30
51.36
44.41
33.68
Depreciation
60.67
48.68
29.44
22.49
19.56
13.97
15.10
Profit Before Tax
-9.05
-3.64
3.75
-11.80
-4.81
-8.87
-8.33
Tax
0.15
0.11
-2.43
-3.99
0.17
0.27
0.13
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-9.20
-3.75
6.18
-7.81
-4.98
-9.14
-8.46
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-9.20
-3.75
6.18
-7.81
-4.98
-9.14
-8.46
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-9.20
-3.75
6.18
-7.81
-4.98
-9.14
-8.46
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
144.81
150.23
109.30
74.27
37.71
17.25
19.27
Earnings per share (EPS)
-0.22
-0.1
0.17
-0.26
-0.27
-0.43
-0.15
Diluted Earnings per share
-0.22
-0.1
0.17
-0.26
-0.27
-0.43
-0.15
Operating Profit Margin (Excl OI)
1.44%
2.74%
0.49%
-1.29%
-0.87%
-1.45%
-9.71%
Gross Profit Margin
15.42%
15.78%
18.57%
8.26%
15.09%
6.3%
9.6%
PAT Margin
-2.75%
-1.32%
3.46%
-6.03%
-5.1%
-11.29%
-12.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Sep 2024 is 17.20% vs 59.76% in Sep 2023
Consolidate Net Profit
YoY Growth in year ended Sep 2024 is -142.11% vs -161.29% in Sep 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Sep 2024 is 15.93% vs 86.47% in Sep 2023
Interest
YoY Growth in year ended Sep 2024 is 22.33% vs 281.48% in Sep 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Sep 2024 has fallen from Sep 2023
Compare Annual Results Of Quipt Home Medical Corp. With
Figures in Million
Consolidate Annual Results
Change(CAD)
Change(%)
Net Sales
334.64
0
334.64
Other Operating Income
0.00
0.00
0.00
Total Operating income
334.64
0
334.64
Raw Material Cost
154.46
0
154.46
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
12.64
0
12.64
Selling and Distribution Expenses
167.25
0
167.25
Other Expenses
-1.26
0.00
-1.26
Total Expenditure (Excl Depreciation)
321.71
0
321.71
Operating Profit (PBDIT) excl Other Income
12.93
0.00
12.93
Other Income
0.85
0
0.85
Operating Profit (PBDIT)
66.32
0
66.32
Interest
12.64
0
12.64
Exceptional Items
-2.07
0
-2.07
Gross Profit (PBDT)
180.18
0
180.18
Depreciation
60.67
0
60.67
Profit Before Tax
-9.05
0
-9.05
Tax
0.15
0
0.15
Provisions and contingencies
0
0
0.00
Profit After Tax
-9.20
0
-9.20
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-9.20
0
-9.20
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-9.20
0
-9.20
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
144.81
0
144.81
Earnings per share (EPS)
-0.22
0
-0.22
Diluted Earnings per share
-0.22
0
-0.22
Operating Profit Margin (Excl OI)
1.44%
0%
0.00
1.44%
Gross Profit Margin
15.42%
0%
0.00
15.42%
PAT Margin
-2.75%
0%
0.00
-2.75%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 33.46 Million
in Sep 2024Figures in Million
YoY Growth in year ended Sep 2024 is 17.20% vs 59.76% in Sep 2023
Annual - Consolidate Net Profit
Consolidate Net Profit -0.92 Million
in Sep 2024Figures in Million
YoY Growth in year ended Sep 2024 is -142.11% vs -161.29% in Sep 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.55 Million
in Sep 2024Figures in Million
YoY Growth in year ended Sep 2024 is 15.93% vs 86.47% in Sep 2023
Annual - Interest
Interest 1.26 Million
in Sep 2024Figures in Million
YoY Growth in year ended Sep 2024 is 22.33% vs 281.48% in Sep 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 1.44%
in Sep 2024Figures in %
YoY Growth in year ended Sep 2024 has fallen from Sep 2023






